Market Highlights
The global Nuclear
Imaging Devices Market Share is expected to grow significantly over the
forecast period. It is anticipated that the market is projected to register a
CAGR of 5.1% over the forecast period 2023-2032.
The increasing prevalence of cardiovascular
disorders is one of the key factors driving the nuclear imaging devices
market. As per the report published by the Centers for Disease Control and
Prevention (CDC) in 2017, nearly 92.1 million adults were dealing with at least
one type of cardiovascular disease.
Various other factors such as the advancements in
radiotracers, acceptance of nuclear imaging devices in ambulatory settings,
increasing geriatric population, untapped emerging markets, rise in regulatory
approvals, and increasing investment on diagnostic imaging centers are also
expected to propel the growth of the market.
However, the high cost of the nuclear imaging device,
shorter half-life of radiopharmaceuticals can hamper market growth over
the forecast period.
Key Players
the global nuclear imaging devices market players are
Philips Healthcare,
Digirad Corporation,
Neusoft Medical Systems Co.,
Ltd.,
Progenics Pharmaceuticals
Inc.,
Cannon Inc.,
Surgiceye GmbH,
CMR Naviscan,
Mediso Medical Imaging Systems
Ltd.,
Agfa-Gevaert Group,
General Electric Company,
DDD-Diagnostic A/S,
Spectrum Dynamics Medical,
FMI Medical Systems, Inc.,
Segamicorp, and others.
Segmentation
The global nuclear imaging devices market is segmented based
on technology, application, end user, and region.
·
The global nuclear
imaging devices market outlook, by technology, is segmented into
positron emission tomography (PET), single photon emission computed tomography
(SPECT), and planar scintigraphy. The single-photon-emission computed
tomography (SPECT) are further classified as hybrid SPECT systems and
standalone SPECT systems.
·
Based on application, the market is
segmented into oncology, cardiology, neurology, and others.
·
Based on end user, the market is
segmented into hospitals, diagnostic imaging centers, and others.
·
The diagnostic imaging centers segment is
expected to witness the fastest growth over the forecast period due to rising
adoption of nuclear imaging in diagnostic centers.
Regional Analysis
In the current scope of the study, the segments mentioned
above are covered into the four global regions, namely, the Americas, Europe,
Asia-Pacific, and the Middle East and African region.
The nuclear imaging devices market insights in the Americas
has further been segmented into North America and South America, with the North
American market divided into the US and Canada.
The European nuclear imaging devices market has been
segmented into Western Europe and Eastern Europe. Western Europe has been
classified as Germany, France, the UK, Italy, Spain, and the rest of Western
Europe. The nuclear imaging devices market in Asia-Pacific has been
segmented into Japan, China, India, South Korea, Australia, and the rest of
Asia-Pacific. The nuclear imaging devices market in the Middle East &
Africa has been segmented into the Middle East and Africa.
About US:
Market Research Future (MRFR) enable customers to unravel
the complexity of various industries through Cooked Research Report (CRR),
Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed
Research (CFR), and Market Research & Consulting Services.
Contact us:
Market Research Future (part of Wantstats Research and Media
Private Limited),
99 Hudson Street,5Th Floor, New York,
New York 10013
